Permatage XT Settable Nonabsorbable Hemostatic Bone Putty (OS-PER-1001XT)
Orthocon, Inc. · Decision date Sep 3, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-09-03 for Permatage XT Settable Nonabsorbable Hemostatic Bone Putty (OS-PER-1001XT), submitted by Orthocon, Inc. of Stamford, Connecticut, under 510(k) number K262769. The device falls under classification name Wax, Bone, product code MTJ, with the Orthopedic review panel listed; the application was received 08/04/2026. A SESE decision is a 510(k) clearance, not a PMA approval.
The public record identifies the device as a settable, nonabsorbable hemostatic bone putty but does not describe its components, materials, or any changed item, and no predicate device is named in the available text. The summary is listed as type Special and the record states the submission was not reviewed by a third party, was not a combination product, and had no authorized predetermined change control plan. The specialty field is recorded as Unknown, and clinical performance data, indications, and use instructions are not available here; those would reside in the linked FDA summary document.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Unknown
- Decision date
- Sep 3, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262769
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Orthocon, Inc.
- Product code
- MTJ
- Decision code
- SESE
- Decision date
- Sep 3, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Wax, Bone.
- Applicant
- Orthocon, Inc.
- Product code
- MTJ
- FDA device class
- U
FDA decision timeline
K262769 received
Application receipt date recorded by FDA.
K262769 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Orthocon, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Stamford, CT
Sources and methodology
- Original FDA record: K262769
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records